In the BioHarmony Drug Report Database
Poractant alfa
Curosurf (poractant alfa) is an unknown pharmaceutical. Poractant alfa was first approved as Curosurf on 1999-11-18. It is used to treat newborn respiratory distress syndrome in the USA.
Trade Name
|
Curosurf |
|---|---|
Common Name
|
poractant alfa |
ChEMBL ID
|
CHEMBL1201622 |
Indication
|
newborn respiratory distress syndrome |
Drug Class
|
Pulmonary surfactants; tachykinin (neurokinin) receptor antagonists |
Image (chem structure or protein)
